Is Corcept Therapeutics Incorporated stock a buy or sell right now?

Based on current indicators, Corcept Therapeutics Incorporated shows a Buy signal, supported by strong momentum and a confirmed uptrend.

What is Corcept Therapeutics Incorporated’s RSI?

RSI is 67.76, showing balanced momentum within the normal range.

What does MACD indicate for CORT?

MACD at 1.28 signals bullish momentum with buyers in control.

What are Corcept Therapeutics Incorporated’s key support and resistance levels?

Support sits around $29.09, while resistance is near $42.35. A breakout above $42.35 would open the door for further upside.

Corcept Therapeutics Incorporated

Get $10 bonus on your first $100 deposit for CORT

CORT•NASDAQ

Healthcare

Biotechnology

Get $10 bonus on your first $100 deposit for CORT

$42.49

$0.51(1.21%)

U.S. Market opens in 32h 26m

Corcept Therapeutics Incorporated (CORT) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Corcept Therapeutics Incorporated (NASDAQ:CORT).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

CORT Technical Analysis Summary

Corcept Therapeutics Incorporated stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy

Momentum:Bullish (RSI: 67.76)

Trend Strength:Very Strong (ADX: 40.98)

Volatility:High (ATR: 2.58)

Support/Resistance:$29.09 – $42.35 (Bollinger Bands)

This mix signals that Corcept Therapeutics Incorporated is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 67.76

Bullish

Above midpoint suggests upward bias.

Stochastic %K: 52.45

Neutral

Mid-range signal with no clear trend.

Williams %R: -43.08

Neutral

Balanced market without strong signals.

Rate of Change (ROC): 32.16

Strongly Bullish

Strong upside momentum.

Takeaway:Corcept Therapeutics Incorporated shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: 1.28

Bullish

Bullish, trend momentum is strengthening.

ADX: 40.98

Very Strong

Very strong trend, powerful directional momentum.

ATR (14): 2.58

Medium

Medium volatility, healthy price movement.

CCI (14): 111.05

Bearish Risk

Bearish risk, overbought levels suggest caution.

Takeaway:Corcept Therapeutics Incorporated shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators

Bollinger Bands

Upper Band

$42.35

Middle Band (SMA 20)

$35.72

Lower Band

$29.09

Current Position

Above Upper Band

Takeaway:Corcept Therapeutics Incorporated trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels

Upper Channel

$42.49

Middle Line (EMA 20)

$37.33

Lower Channel

$32.17

Squeeze Status

No Squeeze

Takeaway:Corcept Therapeutics Incorporated trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis

On-Balance Volume10.91M

Money Flow Index77.39Bullish, inflows support continued momentum.

Relative Vigor Index74.92Bullish, price momentum strongly favors buyers.

Overall Takeaway:CORT shows bullish money flow, with volume and vigor supporting buyers.

Technical Trading Signals Summary

Based on the current technical analysis of Corcept Therapeutics Incorporated, here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

Overall Recommendation:Corcept Therapeutics Incorporated currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.